COVID-19: ICU delirium management during SARS-CoV-2 pandemic-pharmacological considerations

COVID-19: ICU delirium management during SARS-CoV-2 pandemic-pharmacological considerations

[...]we know of not a single randomized controlled trial that would support such a decision. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Clinical phenotypes of delirium during crit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care (London, England) England), 2020-06, Vol.24 (1), p.375-375, Article 375
Hauptverfasser: Andrews, Lauren J, Benken, Scott T
Format: Artikel
Sprache:eng
Schlagworte:
Betacoronavirus
Clinical trials
Coronavirus Infections
Coronaviruses
COVID-19
Critical care
Delirium
Dexmedetomidine
Drug therapy
Health aspects
Humans
Intensive care
Intensive Care Units
Letter
Pandemics
Pneumonia, Viral
Psychotropic drugs
Risk factors
SARS Virus
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]we know of not a single randomized controlled trial that would support such a decision. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study.
ISSN:1364-8535
1466-609X
1364-8535
1366-609X
DOI:10.1186/s13054-020-03072-5